Non-alcoholic fatty liver disease (NAFLD) is defined medically as macrovesicular steatosis, or abnormal retention of lipids (fats) sufficient and large enough to distort or replace the nuclei of liver cells among those who consume less than 20 grams (.7 ounces) of alcohol per day. NAFLD, unknown prior to 1980, has become our largest liver health issue nationally and throughout most industrialized nations. Fatty liver disease affects metabolism and usually manifests as obesity and insulin resistance, which are direct co-factors for type 2 diabetes. It can also progress to inflammation of the liver, or non-alcoholic steatohepatitis (NASH), leading to cirrhosis. Ironically, a saturated fat (virgin coconut oil) may prove to be the safest and most effective treatment for NAFLD according to a study published recently (September 2017) in the Journal of the Science and Agriculture of Food. The study, “Virgin coconut oil reverses hepatic steatosis by restoring redox homeostasis and lipid metabolism in male Wistar rats,” noted in its background statement that more nutraceutical offerings are being sought for reversing fatty liver disease. The researchers also noted that earlier studies had demonstrated virgin coconut oil could help prevent NAFLD. This new study intended to see if virgin coconut oil could also reverse existing non-alcoholic fatty liver disease.
Whenever parasites are mentioned it is usually considered a third world or developing nation issue. Phrases such as “lovely place, nice people, but don’t drink the water” are common jokes that have some basis in truth. Although our culture is programmed to think all illnesses are derived from viruses and some bacteria, the USA also has its share of parasite issues. The CDC openly admits this in a May 2017 report on its website: "Outbreaks of a parasitic infection linked to swimming pools and water playgrounds are increasingly being reported to CDC, with twice as many outbreaks in 2016 as in 2014." Notice the word "outbreaks" is used, not "cases." The outbreaks recorded from a few states with using a recently installed tracking system involved hundreds of cases reported, overflowing into the thousands range. This specific parasite invasion was from the microscopic Cryptosporidium, aka Crypto, which has a capacity for surviving prescribed pool chlorine content requirements. The chlorine levels in municipal tap water can’t handle this parasite either. There was a neti-pot scare a few years ago when a few folks died from a brain eating amoeba after using their neti-pot with tap water or swimming in fresh water lakes of ponds during summer months. So maybe it’s time to focus a bit more on parasites instead of viruses that sometimes don’t really exist and are usually more difficult to spread than parasites?
Another peer-reviewed study was published this month (August 2017) showing dietary virgin coconut oil has beneficial heart-health effects regarding lipid profile, renal status, hepatic antioxidant defense system, and cardiovascular risks. The study was conducted by researchers in Nigeria in the Department of Medical Biochemistry, Faculty of Basic Medical Sciences, at Federal University. The title of the study is: Dietary Supplementation with Virgin Coconut Oil Improves Lipid Profile and Hepatic Antioxidant Status and Has Potential Benefits on Cardiovascular Risk Indices in Normal Rats. This new study and many other previous studies clearly contradict the propaganda espoused by Big Pharma and the U.S. Government dietary advice, which has been waging a war against saturated fats since the 1970s and the McGovern Report that promoted the false hypothesis that saturated fats led to an increase in lipid cholesterol levels and an increased risk for heart disease. This theory, the lipid theory of heart disease, has been shown to be false repeatedly by the published medical literature, yet it still remains the official USDA dietary advice.
According to the American Academy of Pediatrics (AAP), 25 percent of commercial infant formulas are soy based. In an August 2017 article in the online publication Undark, publisher Deborah Blum brought up the soy formula for infants controversy by interviewing Dr. Jack Taylor, M.D., Ph.D., who is heading research on the effects of soy on infants at the University of North Carolina, funded by the NIH. The research follows up on children’s health development among three categories of infant feeding: breast milk; cow’s milk formulas; and soy formulas. This research group’s most recent paper, “Soy Formula and Epigenetic Modifications” determined a genetic change with vaginal cells among young girls fed soy milk as infants. In her article Blum points out: “Research shows that soy milk and soy formula contain up to 4500 times the level of phytoestrogens found in cow’s milk or breastmilk. … consider further, that a baby on a soy formula diet is being repeatedly dosed every day.” Dr. Taylor states: “Well, you are absolutely correct that these babies are getting a lot higher dose of a known estrogenic compound than they’ll ever get from BPA or an endocrine disruptor like that.” Another study published earlier in the Lancet concluded: "Circulating concentrations of isoflavones in the seven infants fed soy-based formula were 13,000 – 22, 000 times higher than plasma oestradiol [a type of estrogen] concentrations in early life, and may be sufficient to exert biological effects, whereas the contribution of isoflavones from breast-milk and cow-milk is negligible."
Among medical marijuana proponents there has been a lot of discussion about the various ways of combining coconut oil and cannabis as an ideal carrier for combining cannabis' external cannabinoids with the body’s internal cannabinoid system for healing. At first this combination was used to facilitate suppositories that when inserted rectally would somehow allow those who are THC intolerant to absorb full spectrum plant cannabis' benefits to be absorbed without the high. Then the coconut oil with cannabis was contained in capsules to create standardized cannabis edibles for medical consumption. This is what 77 year old Stan Rutner used to cure his terminal lung and brain cancer during hospice under his daughter Corrine’s and son-in-law John Malanca’s custody in California.
Forty percent of women today are obese. Many believe obesity is a precursor to diabetes, which if not reversed will lead to further health complications, and even be life threatening. However, a recent study looking at the effects of coconut oil on glycemia and inflammation demonstrated that obesity alone may not be the culprit. What the researchers discovered indicates that inflammation has a greater impact on insulin resistance and high blood sugar than excess fat. This could be argued, since adipose fats do release toxins over time that do create inflammation. But there are diabetes 2 patients who are not obese. Obesity in women has also been considered a factor in infertility, which this study also attempted to determine. Inadvertently, the study’s findings disclosed even more about the health protective qualities of coconut oil.
A recent 2017 study has determined that pure dietary saturated fats, especially coconut oil, can ease the suffering from inflammatory bowel diseases such as Crohn’s disease. This study was conducted at Case Western Reserve University in Cleveland, Ohio, a private institution well known for independent research. The study was reported in Science Daily June 22, 2017. Mice were fed only plant based fats such as cocoa butter and coconut oil. The mice fed coconut oil or cocoa butter had fewer kinds of gut bacteria. Their gut microbiome content had been positively altered to a healthier balance by 30 percent.
Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming an international epidemic. The mainstream medical mantra for its underlying cause is "fat consumption." However, "fat" is a very general term and does not distinguish between traditional healthy fats and unhealthy modern processed fats and oils. The common belief is that saturated fat is the culprit in fatty liver disease, but a new study published in the July 4, 2017 European Journal of Nutrition comes to a different conclusion. This peer reviewed study, "Chronic consumption of fructose in combination with trans fatty acids but not with saturated fatty acids induces nonalcoholic steatohepatitis with fibrosis in rats," examined more closely the effects of trans fatty acids (from vegetable oils derived from corn and soybeans) versus saturated fats, found in traditional fats such as butter, coconut oil, and palm oil. The study’s title gives away their conclusion: fructose is bad for the liver, but it is worse with trans fats than it is with saturated fats.
A Penn State Medical School epidemiological study, reported by Science Daily, is urging physicians to not prescribe statin drugs for Parkinson’s disease symptoms. Evidently, due to earlier studies, cholesterol reducing drugs were considered preventative of Parkinson’s disease. Amazingly, this practice had been going on for some time, thanks to several questionable, and conflicting studies of statin use and Parkinson’s disease. The most recent study was conducted at the Penn State College of Medicine earlier this year (2017.) Their conclusion asserts that statin drugs should not be used as a Parkinson’s disease (PD) preventative. A previous study claimed patients who stopped taking statin drugs were more prone to Parkinson’s disease, thus statin drugs were helpful for preventing Parkinson’s. The Penn State study provided evidence that the opposite is true. Statin drug use can lead to Parkinson’s disease.
As we have reported frequently here at Health Impact News, sales of drugs to lower cholesterol are the top selling drugs of all time. It is a $100 billion a year industry. The cholesterol-lowering drug Lipitor is the best-selling drug of all time, grossing over $140 billion, with no serious close competitors in the history of pharmaceutical drugs. One out of every four Americans over the age of 50 is taking a statin drug to lower their cholesterol. However, these block buster drugs have run through their patent life, and now generics dominate the market. So Big Pharma is looking at new ways to patent new drugs to lower your cholesterol. The latest? A vaccine is being developed to lower your cholesterol. In recent years, class action lawsuits have been stacking up against statin drug manufacturers due to the terrible side effects, including diabetes. Is this another reason for turning to vaccines to "cure" cholesterol? In this country, lawsuits against vaccines are prohibited while civil suits against prescription or over-the-counter drugs are allowed.